An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenetic evolution with prognostic implications

To model the cytogenetic evolution in gastrointestinal stromal tumour (GIST), an oncogenetic tree model was reconstructed using comparative genomic hybridization data from 203 primary GISTs (116 gastric and 87 intestinal GISTs, including 151 newly analysed cases), with follow‐up available in 173 cases (mean 40 months; maximum 133 months). The oncogenetic tree model identified three major cytogenetic pathways: one initiated by − 14q, one by − 1p, and another by − 22q. The − 14q pathway mainly characterized gastric tumours with predominantly stable karyotypes and more favourable clinical course. On the other hand, the − 1p pathway was more characteristic of intestinal GISTs, with an increased capacity for cytogenetic complexity and more aggressive clinical course. Loss of 22q, more closely associated with − 1p than − 14q, appeared to initiate the critical transition to an unfavourable cytogenetic subpathway. This − 22q pathway included accumulation of + 8q, − 9p, and − 9q, which could all predict disease‐free survival in addition to tumour site. Thus, insights into the cytogenetic evolution obtained from oncogenetic tree models may eventually help to gain a better understanding of the heterogeneous site‐dependent biological behaviour of GISTs. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  M. Ladanyi,et al.  Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  S. Knuutila,et al.  Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas. , 1998, Human pathology.

[3]  M. Risio,et al.  Gastrointestinal stromal tumor, uncommitted type, with monosomies 14 and 22 as the only chromosomal abnormalities. , 1998, Cancer genetics and cytogenetics.

[4]  Feng Jiang,et al.  Inferring Tree Models for Oncogenesis from Comparative Genome Hybridization Data , 1999, J. Comput. Biol..

[5]  S. Hirota,et al.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.

[6]  S. Knuutila,et al.  DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. , 2000, Cancer research.

[7]  S. Steigen,et al.  Gastrointestinal Stromal Tumors with Internal Tandem Duplications in 3′ End of KIT Juxtamembrane Domain Occur Predominantly in Stomach and Generally Seem to Have a Favorable Course , 2003, Modern Pathology.

[8]  G. Klein,et al.  Evolution of tumours and the impact of molecular oncology , 1985, Nature.

[9]  A. Hagemeijer,et al.  Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity , 2004, The Journal of pathology.

[10]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[11]  B. Gunawan,et al.  Biological and clinical significance of cytogenetic abnormalities in low-risk and high-risk gastrointestinal stromal tumors. , 2002, Human pathology.

[12]  J. Fletcher,et al.  Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. , 2002, Human pathology.

[13]  L. Sobin,et al.  Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.

[14]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[15]  W. El-Rifai,et al.  Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. , 2002, Human pathology.

[16]  L. Sobin,et al.  Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[17]  L. Kindblom,et al.  Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors). , 2000, Cancer genetics and cytogenetics.

[18]  Feng Jiang,et al.  Distance-Based Reconstruction of Tree Models for Oncogenesis , 2000, J. Comput. Biol..

[19]  E. Wardelmann,et al.  Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. , 2004, The Journal of molecular diagnostics : JMD.

[20]  D. Gisselsson,et al.  Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution , 2001, Genes, chromosomes & cancer.

[21]  Hoguen Kim,et al.  Putative chromosomal deletions on 9p, 9q and 22q occur preferentially in malignant gastrointestinal stromal tumors , 2000, International journal of cancer.

[22]  Samuel Singer,et al.  PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.

[23]  L. Sobin,et al.  Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. , 1999, The American journal of surgical pathology.

[24]  P. Terrier,et al.  Consistent DNA losses on the short arm of chromosome 1 in a series of malignant gastrointestinal stromal tumors. , 2001, Cancer genetics and cytogenetics.

[25]  J. Lee,et al.  Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases , 2005, Laboratory Investigation.

[26]  C. Enders,et al.  Site‐independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours , 2004, The Journal of pathology.

[27]  M. Debiec‐Rychter,et al.  Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. , 2001, Cancer genetics and cytogenetics.

[28]  L. Sobin,et al.  A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential , 2004, Laboratory Investigation.

[29]  A. Hagemeijer,et al.  Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site , 2004, Modern Pathology.

[30]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[31]  Mattias Höglund,et al.  Coping with complexity. multivariate analysis of tumor karyotypes. , 2002, Cancer genetics and cytogenetics.

[32]  B. Gunawan,et al.  Maximum likelihood estimation of oncogenetic tree models. , 2004, Biostatistics.

[33]  C. Tzeng,et al.  Biological significance of chromosomal imbalance aberrations in gastrointestinal stromal tumors. , 2004, Journal of biomedical science.

[34]  P. D. Dal Cin,et al.  Molecular cytogenetic definition of three distinct chromosome arm 14q deletion intervals in gastrointestinal stromal tumors , 2001, Genes, chromosomes & cancer.

[35]  R. Schneider-Stock,et al.  KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin. , 2003, Human pathology.